FOLD FY 2021 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$306M+17.1% YoY

Gross Profit

$271M88.7% margin

Operating Income

-$206M-67.6% margin

Net Income

-$250M-82.0% margin

EPS (Diluted)

$-0.92

Cash Flow

Operating Cash Flow

-$202M

Free Cash Flow

-$206M

Stock-Based Comp.

$58M

Balance Sheet

Total Assets

$905M

Total Liabilities

$598M

Stockholders' Equity

$307M

Cash & Equivalents

$245M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$306M	$261M	+17.1%
Gross Profit	$271M	$230M	+17.9%
Operating Income	-$206M	-$247M	+16.4%
Net Income	-$250M	-$277M	+9.5%